comparemela.com

Latest Breaking News On - Stefan glombitza - Page 8 : comparemela.com

EQS-News: Formycon publishes results for financial year 2022

EQS-News: Formycon AG / Key word(s): Annual Results/Annual Report Formycon publishes results for financial year 2022 27.04.202.

United-kingdom
Japan
Canada
United-states
Germany
Australia
America
German
Bioeq-gmb
Johnson
Stefan-glombitza
Gmbh-co

Enno Spillner appointed Chief Financial Officer (CFO) of Formycon AG

EQS-News: Formycon AG / Key word(s): PersonnelEnno Spillner appointed Chief Financial Officer (CFO) of Formycon AG 07.02.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release // February 7, 2023  Enno Spillner appointed Chief Financial Officer (CFO) of Fo.

Germany
Australia
Japan
United-states
Paris
France-general
France
Canada
Munich
Bayern
America
Enno-spillner

EQS-News: Enno Spillner appointed Chief Financial Officer (CFO) of Formycon AG

EQS-News: Formycon AG / Key word(s): Personnel Enno Spillner appointed Chief Financial Officer (CFO) of Formycon AG 07.02.202.

Germany
Australia
Japan
Canada
Paris
France-general
France
Munich
Bayern
Enno-spillner
Andreas-seidl
Nicola-mikulcik

Formycon Reports its Nine-month Figures for 2022

EQS-News: Formycon AG / Key word(s): 9 Month figures/ForecastFormycon Reports its Nine-month Figures for 2022 25.11.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement. Press Release // November 25, 2022 Formycon Reports its Nine-month Figures for 2022 Group turnover.

Munich
Bayern
Germany
Australia
Japan
United-states
Canada
United-kingdom
America
Great-britain
German
Bioeq-gmb

Broad-acting antiviral SARS-CoV-2 drug FYB207 shows longer half-life and improved efficacy through o

EQS-News: Formycon AG / Key word(s): Study/Study resultsBroad-acting antiviral SARS-CoV-2 drug FYB207 shows longer half-life and improved efficacy through optimized molecular design in preclinical studies 03.11.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement. Press Rel.

Munich
Bayern
Germany
Australia
Japan
United-states
Canada
America
Andreas-seidl
Stefan-glombitza
Corporate-communications
Paul-ehrlich-institute

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.